From: Systematic analyses of glutamine and glutamate metabolisms across different cancer types
| Type | Cancer tissue (samples) | Control tissue (samples) |
|---|---|---|
| Bladder urothelial carcinoma (BLCA) | 182 | 18 |
| Breast invasive carcinoma (BRCA) | 994 | 106 |
| Colon adenocarcinoma (COAD) | 233 | 21 |
| Head and neck squamous cell carcinoma (HNSC) | 303 | 37 |
| Kidney chromophobe (KICH) | 66 | 25 |
| Kidney renal clear cell carcinoma (KIRC) | 480 | 71 |
| Kidney renal papillary cell carcinoma (KIRP) | 141 | 30 |
| Liver hepatocellular carcinoma (LIHC) | 134 | 49 |
| Lung adenocarcinoma (LUAD) | 470 | 58 |
| Prostate adenocarcinoma (PRAD) | 195 | 45 |
| Thyroid carcinoma (THCA) | 494 | 58 |